193 related articles for article (PubMed ID: 11752393)
1. Tumor attenuation by combined heparan sulfate and polyamine depletion.
Belting M; Borsig L; Fuster MM; Brown JR; Persson L; Fransson LA; Esko JD
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):371-6. PubMed ID: 11752393
[TBL] [Abstract][Full Text] [Related]
2. Single chain fragment anti-heparan sulfate antibody targets the polyamine transport system and attenuates polyamine-dependent cell proliferation.
Welch JE; Bengtson P; Svensson K; Wittrup A; Jenniskens GJ; Ten Dam GB; Van Kuppevelt TH; Belting M
Int J Oncol; 2008 Apr; 32(4):749-56. PubMed ID: 18360702
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of naphthoxyloside cytotoxicity on human tumor cells by difluoromethylornithine and spermine-NONOate.
Cheng F; Johnsson R; Nilsson J; Fransson LA; Ellervik U; Mani K
Cancer Lett; 2009 Jan; 273(1):148-54. PubMed ID: 18783879
[TBL] [Abstract][Full Text] [Related]
4. Proteoglycan involvement in polyamine uptake.
Belting M; Persson S; Fransson LA
Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):317-23. PubMed ID: 10024506
[TBL] [Abstract][Full Text] [Related]
5. Effects of polyamine depletion by alpha-difluoromethylornithine on in vitro and in vivo biological properties of 4T1 murine mammary cancer cells.
Jun JY; Griffith JW; Bruggeman R; Washington S; Demers LM; Verderame MF; Manni A
Breast Cancer Res Treat; 2007 Sep; 105(1):29-36. PubMed ID: 17143592
[TBL] [Abstract][Full Text] [Related]
6. Novel lysine-spermine conjugate inhibits polyamine transport and inhibits cell growth when given with DFMO.
Weeks RS; Vanderwerf SM; Carlson CL; Burns MR; O'Day CL; Cai F; Devens BH; Webb HK
Exp Cell Res; 2000 Nov; 261(1):293-302. PubMed ID: 11082299
[TBL] [Abstract][Full Text] [Related]
7. Effects of polyamine depletion by alpha-difluoromethylornithine on in vitro and in vivo biological properties of 4T1 murine mammary cancer cells.
Jun JY; Griffith JW; Bruggeman R; Washington S; Demers LM; Verderame MF; Manni A
Breast Cancer Res Treat; 2008 Jan; 107(1):33-40. PubMed ID: 17333337
[TBL] [Abstract][Full Text] [Related]
8. Polyamine depletion and growth inhibition in Candida albicans and Candida tropicalis by alpha-difluoromethylornithine and cyclohexylamine.
Pfaller MA; Riley J; Gerarden T
J Med Vet Mycol; 1988 Apr; 26(2):119-26. PubMed ID: 3138402
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of polyamine homologues on the prevention of DL-alpha-difluoromethylornithine-mediated inhibition of malignant cell growth and normal immune response.
Singh AB; Thomas TJ; Thomas T; Singh M; Mann RA
Cancer Res; 1992 Apr; 52(7):1840-7. PubMed ID: 1551114
[TBL] [Abstract][Full Text] [Related]
10. Antimetastatic activity of DL-alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, in mice.
Sunkara PS; Rosenberger AL
Cancer Res; 1987 Feb; 47(4):933-5. PubMed ID: 3100031
[TBL] [Abstract][Full Text] [Related]
11. Suramin selectively inhibits carcinoma cell growth that is dependent on extracellular polyamines.
Sandgren S; Belting M
Anticancer Res; 2003; 23(2B):1223-8. PubMed ID: 12820375
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with 2-difluoromethylornithine and a polyamine transport inhibitor against murine squamous cell carcinoma.
Chen Y; Weeks RS; Burns MR; Boorman DW; Klein-Szanto A; O'Brien TG
Int J Cancer; 2006 May; 118(9):2344-9. PubMed ID: 16331620
[TBL] [Abstract][Full Text] [Related]
13. The gastrointestinal polyamine source depletion enhances DFMO induced polyamine depletion in MCF-7 human breast cancer cells in vivo.
Levêque J; Burtin F; Catros-Quemener V; Havouis R; Moulinoux JP
Anticancer Res; 1998; 18(4A):2663-8. PubMed ID: 9703925
[TBL] [Abstract][Full Text] [Related]
14. HIV-Tat protein transduction domain specifically attenuates growth of polyamine deprived tumor cells.
Mani K; Sandgren S; Lilja J; Cheng F; Svensson K; Persson L; Belting M
Mol Cancer Ther; 2007 Feb; 6(2):782-8. PubMed ID: 17308074
[TBL] [Abstract][Full Text] [Related]
15. Synergistic inhibition of polyamine synthesis and growth by difluoromethylornithine plus methylthioadenosine in methylthioadenosine phosphorylase-deficient murine lymphoma cells.
Yamanaka H; Kubota M; Carson DA
Cancer Res; 1987 Apr; 47(7):1771-4. PubMed ID: 3102048
[TBL] [Abstract][Full Text] [Related]
16. Effects of polyamine synthesis inhibitors on primary tumor features and metastatic capacity of human breast cancer cells.
Manni A; Washington S; Hu X; Griffith JW; Bruggeman R; Demers LM; Mauger D; Verderame MF
Clin Exp Metastasis; 2005; 22(3):255-63. PubMed ID: 16158253
[TBL] [Abstract][Full Text] [Related]
17. Increased survival of L1210 leukemic mice by prevention of the utilization of extracellular polyamines. Studies using a polyamine-uptake mutant, antibiotics and a polyamine-deficient diet.
Ask A; Persson L; Heby O
Cancer Lett; 1992 Sep; 66(1):29-34. PubMed ID: 1451093
[TBL] [Abstract][Full Text] [Related]
18. Modulations of glypican-1 heparan sulfate structure by inhibition of endogenous polyamine synthesis. Mapping of spermine-binding sites and heparanase, heparin lyase, and nitric oxide/nitrite cleavage sites.
Ding K; Sandgren S; Mani K; Belting M; Fransson LA
J Biol Chem; 2001 Dec; 276(50):46779-91. PubMed ID: 11577085
[TBL] [Abstract][Full Text] [Related]
19. Polyamine depletion inhibits apoptosis following blocking of survival pathways in human chondrocytes stimulated by tumor necrosis factor-alpha.
Stanic I; Facchini A; Borzì RM; Vitellozzi R; Stefanelli C; Goldring MB; Guarnieri C; Facchini A; Flamigni F
J Cell Physiol; 2006 Jan; 206(1):138-46. PubMed ID: 15965903
[TBL] [Abstract][Full Text] [Related]
20. Individual and combined effects of alpha-difluoromethylornithine and ovariectomy on the growth and polyamine milieu of experimental breast cancer in rats.
Manni A; Badger B; Glikman P; Bartholomew M; Santner S; Demers L
Cancer Res; 1989 Jul; 49(13):3529-34. PubMed ID: 2499419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
